The abortion pill is many times more dangerous than the FDA claimed, with more than one in 10 women suffering serious complications, a new study found.
About 11.2% of 154,554 women experienced a “serious adverse event” after taking the mifepristone abortion pill in 2023, according to new research commissioned by the Foundation for the Restoration of America and released Monday.
That works out to about 17,310 women who suffered serious adverse events, which can include hemorrhaging, needing a blood transfusion, an emergency room visit, and even deadly conditions like sepsis.
This is about 22 times higher than what the FDA put on its label for the brand Mifeprex in 2023 — the FDA cited clinical studies saying less than 0.5% of women suffered “serious adverse reactions” to mifepristone.
The two-pill chemical abortion regimen, mifepristone usually followed by misoprostol, aims to…
